Skip to main content
Fig. 3 | Annals of Clinical Microbiology and Antimicrobials

Fig. 3

From: Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland

Fig. 3

Minimal inhibitory concentration (MIC) distributions for respiratory Enterobacterales and P. aeruginosa isolates from ventilated COVID-19 patients. Vertical dashed lines indicate the EUCAST clinical resistant breakpoint values for piperacillin/tazobactam (TZP), cefepime (FEP), meropenem (MEM), gentamicin (GEN), tobramycin (TOB), amikacin (AMI) and trimethoprim/sulfamethoxazole (SXT) for Enterobacterales (orange) and P. aeruginosa (blue) isolates, respectively. In the case of plazomicin (PLZ), the vertical dashed line indicates the FDA-identified interpretative criteria. In the case of APR (apramycin), vertical dashed lines indicate the proposed ECOFF values [25]

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us